The sodium-glucose cotransporter-2 inhibitor canagliflozin alleviates endothelial dysfunction in a rat bypass model - Ma, Ming; Lian, Shuo; Kraft, Patricia; Mayer, Tobias; Sayour, Alex Ali; Karck, Matthias; Szabó, Gábor; Korkmaz-İçöz, Sevil (Biochemical pharmacology, 2026)
Online verfügbar: 4. Dezember 2025, Artikelversion: 8. Dezember 2025